PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Methyl salicylate
Presentation Product Chemical substance Chapter Items dispensed
Methyl salicylate 30% / Menthol 8% cream
1003020N0AABABA
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases 1,546
Methyl salicylate 50% ointment
1003020N0AAABAB
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases 9
Generic Balmosa cream
1003020N0AAAKAK
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases No data available
Generic Deep Heat rub
1003020N0AAATAT
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases No data available
Generic Dubam spray
1003020N0AAAMAM
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases No data available
Generic PR Heat spray
1003020N0AAAUAU
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases No data available
Generic Radian B Muscle lotion
1003020N0AAASAS
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases No data available
Generic Radian B Pain Relief spray
1003020N0AAAYAY
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases No data available
Hydroxyethyl salicylate 6% / Methyl nicotinate 1.6% spray
1003020N0AAAZAZ
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases No data available
Methyl salicylate 25% liniment
1003020N0AAAAAA
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases No data available
Methyl salicylate 70mg/g topical solution
1003020N0AABBBB
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases No data available
Methyl salicylate liquid
1003020N0AAAFAF
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.